Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma

被引:9
作者
Wang, Shan [1 ,2 ]
Huo, Xiaofang [2 ]
Yang, Yiping [1 ]
Mo, Yingxi [1 ]
Kollipara, Rahul K. [2 ]
Kittler, Ralf [2 ,3 ,4 ,5 ,6 ]
机构
[1] Guangxi Med Univ, Dept Res, Canc Hosp, Nanning, Guangxi Zhuang, Peoples R China
[2] Univ Texas Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA
[5] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Reprod Biol Sci, Dallas, TX USA
[6] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
Ewing sarcoma; USP9X; EWS-FLI1; Ubiquitination; WP1130; SHORT INTERFERING RNAS; EWS/FLI-1; PHENOTYPE; SURVIVAL; THERAPY; PROGRAM; FUSION;
D O I
10.1016/j.canlet.2022.215984
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The neomorphic transcription factor EWS-FLI1 is a key driver of Ewing sarcoma. Ablation of EWS-FLI1 may present a promising therapeutic strategy for this malignancy. Here we found that the deubiquitinase, ubiquitin specific peptidase 9 X-linked (USP9X) stabilizes EWS-FLI1 protein expression in Ewing sarcoma. We show that USP9X binds the ETS domain of EWS-FLI1 in Ewing sarcoma cells and deubiquitinates EWS-FLI1 and that USP9X and EWS-FLI1 protein expression is correlated in clinical Ewing sarcoma specimens. We found that treatment of Ewing sarcoma cells with the USP9X inhibitor WP1130 mediates rapid EWS-FLI1 degradation in vitro and in vivo which coincides with reduced growth of Ewing sarcoma cells and tumors. Our results suggest that USP9X might be a potential therapeutic target to mediate EWS-FLI1 depletion in Ewing sarcoma.
引用
收藏
页数:8
相关论文
共 50 条
[31]   Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target [J].
Herrero-Martin, D. ;
Osuna, D. ;
Ordonez, J. L. ;
Sevillano, V. ;
Martins, A. S. ;
Mackintosh, C. ;
Campos, M. ;
Madoz-Gurpide, J. ;
Otero-Motta, A. P. ;
Caballero, G. ;
Amaral, A. T. ;
Wai, D. H. ;
Braun, Y. ;
Eisenacher, M. ;
Schaefer, K-L ;
Poremba, C. ;
de Alava, E. .
BRITISH JOURNAL OF CANCER, 2009, 101 (01) :80-90
[32]   EWS-FLI-1 Regulates the Neuronal Repressor Gene REST, Which Controls Ewing Sarcoma Growth and Vascular Morphology [J].
Zhou, Zhichao ;
Yu, Ling ;
Kleinerman, Eugenie S. .
CANCER, 2014, 120 (04) :579-588
[33]   USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma [J].
Mallard, Halle J. ;
Wan, Shibiao ;
Nidhi, Prakriti ;
Hanscom-Trofy, Yvan D. ;
Mohapatra, Bhopal ;
Woods, Nicholas T. ;
Lopez-Guerrero, Jose Antonio ;
Llombart-Bosch, Antonio ;
Machado, Isidro ;
Scotlandi, Katia ;
Kreiling, Natasha F. ;
Perry, Megan C. ;
Mirza, Sameer ;
Coulter, Donald W. ;
Band, Vimla ;
Band, Hamid ;
Ghosal, Gargi .
MOLECULAR CANCER RESEARCH, 2023, 21 (11) :1186-1204
[34]   The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition [J].
Peddaboina, Chander ;
Jupiter, Daniel ;
Fletcher, Steven ;
Yap, Jeremy L. ;
Rai, Arun ;
Tobin, Richard P. ;
Jiang, Weihua ;
Rascoe, Philip ;
Rogers, M. Karen Newell ;
Smythe, W. Roy ;
Cao, Xiaobo .
BMC CANCER, 2012, 12
[35]   USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy [J].
Ma, Tao ;
Chen, Wei ;
Zhi, Xiao ;
Liu, Hao ;
Zhou, Yue ;
Chen, Brayant Wei ;
Hu, Liqiang ;
Shen, Jian ;
Zheng, Xiaoxiao ;
Zhang, Shufen ;
Zhang, Bo ;
Li, Haijun ;
Liang, Tingbo .
CANCER LETTERS, 2018, 436 :129-138
[36]   Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition [J].
Roldan-Romero, Juan M. ;
Valdivia, Carlos ;
Santos, Maria ;
Lanillos, Javier ;
Maroto, Pablo ;
Anguera, Georgia ;
Calsina, Bruna ;
Martinez-Montes, Angel ;
Monteagudo, Maria ;
Mellid, Sara ;
Leandro-Garcia, Luis J. ;
Montero-Conde, Cristina ;
Cascon, Alberto ;
Roncador, Giovanna ;
Coloma, Javier ;
Robledo, Mercedes ;
Rodriguez-Antona, Cristina .
INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (06) :1300-1312
[37]   Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model [J].
Takigami, Iori ;
Ohno, Takatoshi ;
Kitade, Yukio ;
Hara, Akira ;
Nagano, Akihito ;
Kawai, Gou ;
Saitou, Mitsuru ;
Matsuhashi, Aya ;
Yamada, Kazunari ;
Shimizu, Katsuji .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (01) :216-226
[38]   miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness [J].
De Feo, Alessandra ;
Pazzaglia, Laura ;
Ciuffarin, Lisa ;
Mangiagli, Fabio ;
Pasello, Michela ;
Simonetti, Elisa ;
Pellegrini, Evelin ;
Ferrari, Cristina ;
Bianchi, Giuseppe ;
Spazzoli, Benedetta ;
Scotlandi, Katia .
CANCERS, 2022, 14 (07)
[39]   Screening of HLA-A2.1-Restricted CTL Epitopes Derived from Ewing's Sarcoma EWS-FLI1 Fusion Protein by Using Molecular Simulation [J].
Cao Kai ;
Huang Lu ;
Lin Zhihua ;
Shu Yong ;
Han Zhimin ;
Huang Shanhu ;
Liao Xiang ;
Wang Yuanqiang ;
Peng Fangyi ;
An Hong .
ACTA CHIMICA SINICA, 2010, 68 (13) :1277-1284
[40]   High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability [J].
He, Tao ;
Surdez, Didier ;
Rantala, Juha K. ;
Haapa-Paananen, Saija ;
Ban, Jozef ;
Kauer, Maximilian ;
Tomazou, Eleni ;
Fey, Vidal ;
Alonso, Javier ;
Kovar, Heinrich ;
Delattre, Olivier ;
Iljin, Kristiina .
GENE, 2017, 596 :137-146